Concord Wealth Partners Vertex Pharmaceuticals Inc Transaction History

Concord Wealth Partners

  • $591 Million
  • Q3 2024

A detailed history of Concord Wealth Partners transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Concord Wealth Partners holds 2,646 shares of VRTX stock, worth $1.07 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
2,646
Previous 2,297 15.19%
Holding current value
$1.07 Million
Previous $1.08 Million 14.31%
% of portfolio
0.21%
Previous 0.19%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024
BUY
$460.0 - $505.78 $160,540 - $176,517
349 Added 15.19%
2,646 $1.23 Million
Q2 2024

Jul 31, 2024
BUY
$392.81 - $485.53 $258,468 - $319,478
658 Added 40.15%
2,297 $1.08 Million
Q1 2024

Apr 30, 2024
BUY
$407.69 - $446.08 $196,914 - $215,456
483 Added 41.78%
1,639 $685,000
Q4 2023

Apr 30, 2024
BUY
$343.0 - $410.68 $137,200 - $164,272
400 Added 52.91%
1,156 $470,000
Q4 2023

Feb 05, 2024
BUY
$343.0 - $410.68 $137,200 - $164,272
400 Added 52.91%
1,156 $470,000
Q3 2023

Apr 30, 2024
SELL
$338.18 - $362.46 $135,272 - $144,984
-400 Reduced 34.6%
756 $262,000
Q3 2023

Oct 25, 2023
BUY
$338.18 - $362.46 $43,287 - $46,394
128 Added 20.38%
756 $262,000
Q2 2023

Aug 07, 2023
BUY
$314.42 - $351.91 $86,779 - $97,127
276 Added 78.41%
628 $220,000
Q1 2023

Apr 26, 2023
BUY
$283.23 - $323.1 $94,032 - $107,269
332 Added 1660.0%
352 $110,000
Q4 2022

Jan 27, 2023
BUY
$285.76 - $321.48 $5,715 - $6,429
20 New
20 $5,000
Q2 2022

Aug 04, 2022
SELL
$234.96 - $292.55 $7,048 - $8,776
-30 Reduced 22.56%
103 $29,000
Q1 2022

Apr 20, 2022
BUY
$221.42 - $260.97 $3,099 - $3,653
14 Added 11.76%
133 $35,000
Q4 2021

Jan 21, 2022
BUY
$177.01 - $223.45 $18,586 - $23,462
105 Added 750.0%
119 $26,000
Q3 2021

Nov 09, 2021
SELL
$181.39 - $202.99 $5,441 - $6,089
-30 Reduced 68.18%
14 $3,000
Q2 2021

Jul 29, 2021
SELL
$187.49 - $221.1 $749 - $884
-4 Reduced 8.33%
44 $9,000
Q1 2021

May 13, 2021
BUY
$207.02 - $241.31 $9,936 - $11,582
48 New
48 $10,000

Others Institutions Holding VRTX

# of Institutions
1,725
Shares Held
221M
Call Options Held
1.58M
Put Options Held
1.36M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $104B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Concord Wealth Partners Portfolio

Follow Concord Wealth Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concord Wealth Partners, based on Form 13F filings with the SEC.

News

Stay updated on Concord Wealth Partners with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email